Related Experiment Videos
Potential and limitations of cochlear implants in children
R C Dowell1, P J Blamey, G M Clark
1Human Communication Research Centre, Melbourne, Australia.
The Annals of Otology, Rhinology & Laryngology. Supplement
|September 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.
Investigational new drugs·1998
Studies of prosody perception by cochlear implant patients.
Audiology : official organ of the International Society of Audiology·1998
Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Modulation detection interference in cochlear implant subjects.
The Journal of the Acoustical Society of America·1998
Intracellular responses of the rat anteroventral cochlear nucleus to intracochlear electrical stimulation.
Brain research bulletin·1998
Language development, interpersonal communication, and academic achievement among Japanese children as assessed by the ALADJIN.
The Annals of otology, rhinology & laryngology. Supplement·2012
Syntactic development in Japanese hearing-impaired children.
The Annals of otology, rhinology & laryngology. Supplement·2012
Language ability in the intermediate-scoring group of hearing-impaired children.
The Annals of otology, rhinology & laryngology. Supplement·2012
Effects of early identification and intervention on language development in Japanese children with prelingual severe to profound hearing impairment.
The Annals of otology, rhinology & laryngology. Supplement·2012
Assessment package for language development in Japanese hearing-impaired children (ALADJIN) as a test battery for the development of practical communication.
The Annals of otology, rhinology & laryngology. Supplement·2012
Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis.
The Annals of otology, rhinology & laryngology. Supplement·2009